Osteoporosis
(OP)
is
a
systemic
and
retrogressive
disease
characterized
by
decreased
bone
density
fragile
microstructure.
Extracellular
vesicles
(EVs),
cell‐free
system
with
phospholipid
bilayer
released
cells
that
cannot
be
replicated,
have
unique
nanostructure,
stable
drug‐loading
capacity,
good
biocompatibility,
playing
an
important
role
in
regulating
the
gut‐skeletal
axis.
A
growing
body
of
research
demonstrates
gut
microbiota
(GM)
influence
development
OS,
while
bacteria‐derived
EVs
(BEVs)
become
new
dialogue
medium
between
bone.
Additionally,
organoids
are
3D
cell
clusters
vitro
highly
simulate
structure
function
corresponding
organs.
Intestinal
organoids‐derived
(IOEVs)
serve
as
another
promising
communication
due
to
their
significant
physiological
effects.
Herein,
three
types
gut‐bone
axes,
including
traditional,
BEVs‐based,
IOEVs‐based
axes
innovatively
proposed.
The
impact
BEVs‐based
on
OP
focused.
comprehensive
summary
will
reveal
relationship
intestinal
provide
solution
therapy.
Abstract
Bacterial
extracellular
vesicles
(BEVs)
are
nanoscale
secreted
by
bacteria.
They
possess
lipid
bilayer
membranes
and
contain
multiple
periplasmic
cytoplasmic
components,
facilitating
their
intercellular
communications
through
transferring
of
various
bioactive
molecules.
Considering
intrinsic
structure,
delivery
capacity,
immunogenic
property,
facile
production,
versatile
modification,
more
studies
have
exploited
BEVs
directly
as
therapeutic
agents
or
engineered
vehicles
for
the
disease
treatment.
Nevertheless,
unprecedented
upsurge
in
highlighted
burgeoning
need
tailoring
them
with
enhanced
efficacies
including
specific
targeting,
subcellular
penetration,
pathological
site
retention,
so
on.
With
this
aspect,
functional
peptides
either
penetrating,
immunostimulating,
biofunctions,
self‐assembly
exhibit
power
to
open
new
avenues.
Functional
can
be
modified
on
surface,
encapsulated
inside
membranes,
even
self‐assembled
into
hydrogel
embedding
around
fully
unleash
potential
BEVs.
Herein,
present
perspective
is
dedicated
overview
most
recent
advancements
exploring
bridging
treatment,
provide
valuable
insights
future
development
innovative
modalities.
Advanced NanoBiomed Research,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 30, 2025
Plant‐derived
extracellular
vesicles
(pEVs)
are
nanosized
that
have
comparable
structure
and
properties
to
EVs
derived
from
mammalian
cells.
Prior
studies
confirmed
pEVs
remarkable
efficacy
in
the
treatment
of
human
diseases,
such
as
cancer.
As
critical
regulators
gene
expression,
microRNAs
(miRNAs)
abundant
pEVs.
However,
their
potential
functional
roles
regulatory
mechanisms
mediating
crosskingdom
regulation
cells
by
remain
undefined.
In
particular,
similarities
differences
miRNA
profiles
various
elusive.
Herein,
isolated
grapefruit,
ginger,
lemon,
grape,
small
RNA
(sRNA)
libraries
constructed
perform
sRNA
sequencing.
Only
15
consistently
expressed
miRNAs
identified
these
Furthermore,
top
20
each
pEV
highly
among
total
miRNAs,
accounting
for
79.93–87.12%.
Through
annotation
analysis
target
genes,
found
be
involved
regulating
progression
cancer
viral
infection.
Taken
together,
this
study
demonstrates
contained
play
a
role
effects
against
genes
highlights
significant
therapeutic
applications
diseases.
Biomedicines,
Год журнала:
2025,
Номер
13(4), С. 847 - 847
Опубликована: Апрель 2, 2025
Introduction:
Osteoporosis
(OP)
is
a
prevalent
condition
marked
by
reduced
bone
density
and
heightened
risk
of
fractures.
Current
treatments
often
have
side
effects,
underscoring
the
need
for
safer
alternatives.
Recent
research
highlights
significant
role
gut
microbiota
their
metabolites
in
maintaining
health.
Notably,
bacterial
outer
membrane
vesicles
(OMVs)
emerged
as
promising
platform
due
to
nanoscale
sizes,
low
toxicity,
drug-loading
capabilities,
excellent
biocompatibility.
Methods:
In
this
study,
we
developed
delivery
system
using
OMVs
derived
from
Pseudomonas
mirabilis
(PM).
By
anchoring
bone-targeting
peptides
PM-OMVs
membrane,
equipped
these
deliver
endogenous
miRNAs
microenvironment
effectively.
Results
Discussion:
The
bone-targeted
(PM-OMVs-BT)
demonstrated
exceptional
abilities
exhibited
favorable
safety
profile
vivo.
Additionally,
LGG-OMVs-BT
were
successfully
internalized
marrow
stromal
cells
(BMSCs)
without
cytotoxicity,
effectively
promoting
osteogenic
differentiation
mineralization.
conclusion,
our
study
indicates
that
PM-OMVs-BT
could
offer
safe
effective
treatment
option
OP.
Molecules and Cells,
Год журнала:
2025,
Номер
unknown, С. 100216 - 100216
Опубликована: Апрель 1, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
progressive
that
affects
the
health
of
approximately
one-third
world's
population.
It
primary
cause
end-stage
disease,
malignancy,
and
transplantation,
resulting
in
great
medical
burden.
No
medications
have
yet
been
approved
by
US
Food
Drug
Administration
(FDA)
for
treating
MASLD
without
inflammation
or
scarring.
Therefore,
development
specific
drugs
to
treat
remains
key
task
ongoing
research
objective.
Extracellular
vesicles
(EVs)
play
an
important
role
communication
between
organs,
tissues,
cells.
Recent
studies
found
intestinal
microbiota
are
closely
related
pathogenesis
progression
MASLD.
EVs
produced
bacteria
(BEVs)
indispensable
this
process.
Thus,
study
provides
new
direction
treatment.
However,
mechanism
which
BEVs
affect
unclear.
investigated
influence
function
Additionally,
we
focus
on
progress
recent
years,
explain
relationship
from
perspectives
glucose
lipid
metabolism,
immune
responses,
homeostasis.
Finally,
summarized
potential
therapeutic
value
other
sources,
such
as
adipocytes,
immunocytes,
stem
cells,
plants.
Osteoporosis
(OP)
is
a
systemic
disease
characterized
by
decreased
bone
density
and
quality,
leading
to
fragile
bones
osteoporotic
fractures
(OPF).
Conventional
treatments
for
OPF
often
exhibit
limited
therapeutic
efficacy
significant
side
effects.
Synthetic
biology-based
bacterial
extracellular
vesicles
(BEVs)
offer
safe
effective
alternative
treatment.
Here,
we
constructed
bioengineered
BEVs
loaded
with
pBMP-2-VEGF
(BEVs-BP)
encapsulated
them
together
IL-4
in
GelMA
hydrogels
form
IL-4/BEVs-BP@GelMA.
Initially,
alleviated
chronic
inflammation
modulating
immune
cells,
while
BEVs-BP
subsequently
enhanced
osteogenesis
vascularization
upregulating
BMP-2
VEGF
expression.
In
vitro,
IL-4/BEVs-BP@GelMA
polarized
M1
macrophages
toward
the
M2
phenotype,
osteogenesis,
increased
angiogenesis.
Moreover,
effectively
promoted
maturation
mineralization
of
organoids
vivo.
Finally,
successfully
accelerated
fracture
repair
mice.
summary,
developed
an
easy-to-build
powerful
biomaterial,
IL-4/BEVs-BP@GelMA,
which
offers
strategy
management.
Bioengineering & Translational Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 16, 2025
Abstract
Non‐small
cell
lung
cancer
(NSCLC)
presents
significant
therapeutic
challenges,
often
characterized
by
aggressive
proliferation
and
metastasis.
This
study
investigates
the
role
of
SLC7A11,
a
ferroptosis‐related
gene,
in
NSCLC
progression
potential
engineered
bacterial
extracellular
vesicles
(BEVs)
expressing
SLC7A11‐targeting
siRNA
as
strategy.
Using
TCGA
GEO
databases,
we
identified
that
SLC7A11
was
significantly
upregulated
tissues.
Functional
assays
demonstrated
knockdown
lines
(NCI‐H2122
NCI‐H647)
via
qPCR,
Western
blot,
immunofluorescence
resulted
impaired
proliferation,
migration,
invasion
abilities.
In
vivo
xenograft
models
further
revealed
inhibited
tumor
growth
metastasis,
corroborated
histological
analyses.
To
enhance
targeted
delivery
siRNA,
BEVs
with
targeting
peptide,
verifying
their
structure
function
through
transmission
electron
microscopy
(TEM)
nanoparticle
tracking
analysis
(NTA).
toxicity
assessments
indicated
safety
for
these
bioengineered
vesicles.
Importantly,
treatment
BEVs‐LCTP‐siSLC7A11
not
only
tumorigenesis
but
also
activated
ferroptosis
pathways,
evidenced
altered
expression
levels
transferrin
metastatic
Our
findings
suggest
promising
approach
to
inhibit
while
activating
ferroptosis,
offering
insights
into
novel
strategies
against
cancer.
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Июнь 23, 2024
Recently,
environmental
temperature
has
been
shown
to
regulate
bone
homeostasis.
However,
the
mechanisms
by
which
cold
exposure
affects
mass
remain
unclear.
In
our
present
study,
we
observed
that
(CT)
decreased
and
quality
in
mice.
Furthermore,
a
transplant
of
exosomes
derived
from
plasma
mice
exposed
(CT-EXO)
can
also
impair
osteogenic
differentiation
BMSCs
decrease
inhibiting
autophagic
activity.
Rapamycin,
potent
inducer
autophagy,
reverse
or
CT-EXO-induced
loss.
Microarray
sequencing
revealed
increases
miR-25-3p
level
CT-EXO.
Mechanistic
studies
showed
inhibit
activity
BMSCs.
It
is
inhibition
release
downregulation
suppress
CT-induced
This
study
identifies
CT-EXO
mediates
osteoporotic
effects
through
autophagy
via
targeting
SATB2,
presenting
novel
mechanism
underlying
effect
on
mass.